The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer’s and Parkinson’s diseases
Critical Path Institute Adds Two Strategic Hires: Beatriz Rendón and Steven Broadbent Beatriz Rendón and Steven Broadbent have joined the Critical Path Institute (C-Path) as the independent non-profit organization c
C-Path Researchers Crack Diseases Through Math, Info Sharing This week, Inside Tucson Business debuts a new monthly feature which profiles the work of young scientists. The idea is to showcas
C-Path Names Respected Business Executive to Lead its Operations Richard T. Myers, a former senior executive with engineering expertise at IBM, has been named Chief Operating Officer of the nonpr
Amgen Biomarker Toolkit – Biomarker Backgrounder Personalized Medicine: In clinical practice, personalized medicine refers to the use of new methods of molecular analysis to bette
C-Path is No. 7 in Reader’s Digest List of 18 Big Ideas to Fix Healthcare Now The November 2008 issue of Reader’s Digest lists 18 big ideas to fix healthcare now and the Critical Path Insitute is listed
FDA & EMEA to Consider Additional Test Results When Assessing New Drug Safety In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration
C-Path Leads Novel Transatlantic Drug Safety Effort Companies receive go ahead from FDA and EMEA to use new improved tests when assessing safety of new drugs.
FDA Soon May Support Biomarker Tests The Food and Drug Administration is poised to throw its support behind a powerful new method of predicting the safety of experimen